Chuck Murry: Can we regenerate heart muscle with stem cells?
Chuck Murry founded and currently directs the Institute for Stem Cell and Regenerative Medicine at the University of Washington. Full bio
Double-click the English transcript below to play the video.
about a patient named Donna.
Donna was in her mid-70s,
of heart disease, however,
of crushing chest pain.
seeking medical attention,
until the pain passed.
to see her physician,
a large heart attack,
in medical parlance.
Donna was never quite the same.
activities she'd previously enjoyed.
keep up with her grandkids,
to go out to the end of the driveway
came by to walk the dog,
dead in the chair.
that was secondary to heart failure.
an ordinary patient.
unfortunately, far too common.
in the entire world.
patients are admitted to the hospital,
health care expense.
billion with a "B" --
twice the annual budget
the heart is the least regenerative organ
a blood clot forms in a coronary artery
is very metabolically active,
of having its blood flow interrupted.
grow back new muscle,
muscle that they have.
their illness progresses to the point
with the body's demand for blood flow.
is the crux of heart failure.
about this problem,
and a statement to the effect of,
we've got to die of something."
as the status quo because we have to.
of stem cells as medicines.
there's not much going on.
and in a month's time,
or become more specialized,
can turn into skin, can turn into brain,
are chock-full of stem cells.
billions of blood cells every day.
are quite stable,
the heart lacks stem cells entirely.
to bring stem cells in from the outside,
the most potent stem cell type,
any of the 240-some cell types
pluripotent stem cells,
into cardiac muscle cells
of patients who have had heart attacks.
with new muscle tissue,
contractile function to the heart.
this was my idea 20 years ago.
I was full of it, and I thought,
and we'll crank this out,
pluripotent stem cells into heart muscle.
human heart muscle in the dish,
because it said, in principle,
to doing the cell counts,
out of 1,000 of our stem cells
of brain and skin and cartilage
that can become anything
to the world of embryology.
had been pondering
what was essentially a Google Map
cardiovascular system.
all of this information
development happen in a dish.
to turn into cardiac muscle --
our current cellular product.
in little three-dimensional clumps
heart muscle cells in it.
little organoids are actually twitching;
up their sleeve.
that live in the Pacific Northwest,
called genome editing
flash green every time they beat.
to begin animal experiments.
into the hearts of rats
experimental heart attacks.
down through my microscope
and we came up with a biochemical cocktail
our "pro-survival cocktail,"
our cells to survive
of transplantation.
through the microscope,
human heart muscle
of this rat's heart.
with the rest of the heart?
that jellyfish gene in them.
like a space probe
into a foreign environment
report back to us
is a zoomed-in view,
of a guinea pig's heart
three grafts of our human cardiac muscle.
running white lines.
human cardiac muscle cells in it.
you can see what we saw
of the injured heart.
to connect with one another
interesting than this.
that's along the bottom,
from the guinea pig's own heart.
with the heartbeat
one-to-one correspondence.
natural pacemaker is calling the shots,
are following in lockstep
what I think is going to be
of a human patient,
a microscopic image
an experimental heart attack
a placebo treatment
of the disease.
that results from the heart attack.
there's a big deficiency in the muscle
how this heart would have a tough time
of the stem-cell-treated hearts.
the monkey's heart muscle in red,
the blue scar tissue,
been able to repopulate it
that we can take our stem cells
into cardiac muscle.
after transplantation,
in synchrony with the rest of the heart,
predictor of a human's response.
that lay in our path, right?
a period of electrical instability.
or irregular heartbeats,
we transplanted them.
we hadn't seen this in smaller animals.
from the fact that our cellular graphs
all act like pacemakers.
we put them into the heart,
with the heart's natural pacemaker
into your orderly household all at once,
and the rhythms of the way you run things,
in a coordinated fashion.
this troubled adolescence period
in the post-adolescent phase,
to their marching orders.
we can actually do quite well
anti-arrhythmia drugs as well.
that we set out to do this:
to the injured heart?
"left ventricular ejection fraction."
the amount of blood
out of the chamber of the heart
like in healthy people,
drops down to about 40 percent,
well on their way to heart failure.
a placebo injection,
fraction is unchanged,
doesn't spontaneously recover.
that received a graft
in cardiac function.
so from 40 to 48 percent.
is that eight points is better
on the market right now
we have put together.
eight points in the clinic,
that would make a large impact
after transplantation.
out to three months,
in ejection fraction.
treated hearts is so good
that these animals had had a heart attack,
from their functional studies.
is to start phase one,
the University of Washington in 2020 --
are safe and effective,
and ship these cells all around the world
with heart disease.
a million or more patients a year.
maybe a decade from now,
will have actual treatments
and not just manage her symptoms.
that stem cells give us the ability
far-fetched science fiction
a transformational effect
of vaccinations and antibiotics.
ABOUT THE SPEAKER
Chuck Murry - Physician, scientistChuck Murry founded and currently directs the Institute for Stem Cell and Regenerative Medicine at the University of Washington.
Why you should listen
Heart failure -- now the number one cause of death worldwide -- is the motivation behind Dr. Chuck Murry's specialized research into innovative treatments. Murry believes that it's not enough simply to help patients who are plagued with chronic disease survive. Instead, his pioneering work seeks to harness the potential of human stem cells to eliminate the disease from the body.
Chuck Murry | Speaker | TED.com